Skip to content
CLADsolve

Trial

Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD

Evidence level: registry entry; no results posted

A registered observational study of plasma and MRI biomarkers of response to extracorporeal photopheresis (ECP) in lung transplant recipients with CLAD, sponsored by Brian Keller.

As of . Primary source: ClinicalTrials.gov NCT07434869.

Summary

The ClinicalTrials.gov entry describes an observational study with an estimated 25 participants who have CLAD and are receiving ECP. Blood samples are taken at three points during ECP, and some participants have two lung MRI scans. The registry states that it is not a study of a new drug or treatment and that participants receive the ECP their doctor already recommended. The listed primary outcomes are the change in donor-derived cell-free DNA and the change in a lung microvascular MRI measurement. No interventions are listed in the structured fields. No results are posted.

Details

registry
ClinicalTrials.gov
registryId
NCT07434869
registryTitle
Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
sponsor
Brian Keller
registryStatus
recruiting
studyType
observational
enrolment
25 (estimated)
startDate
2026-03-25 (actual)
primaryCompletionDate
2030-02-28 (estimated)
condition
Lung Transplant Failure and Rejection; CLAD, Bronchiolitis Obliterans; Extracorporeal Photopheresis
registryLastUpdatePosted
2026-07-14
registryRead
2026-10-10

Sources and links

Related

Links from this record

Linked from (derived)

Known gaps in this record

  • acronym: not shown in the registry entry
  • phase (not listed for observational studies): not shown in the registry entry
  • intervention (none listed in the structured fields): not shown in the registry entry
  • results: none posted in the registry
  • participating centres and investigators: not recorded
  • link to a CLADsolve centre record: not made

Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.